Clinical trial
Amino Acid Therapy to Modify Protein Carbamylation in End Stage Renal Disease: A Randomized Trial
NCT02472834 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amino Acid Therapy to Modify Protein Carbamylation in End Stage Renal Disease: A Randomized Trial
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- December 31, 2020
- Enrollment
- 54 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal failure on dialysis